Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden flag Sweden · Delayed Price · Currency is SEK
157.80
+5.00 (3.27%)
Sep 18, 2025, 12:49 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Hereditary Diseases
130.14M
Log In
Log In
Log In
Log In
Hereditary Diseases Growth
18.26%
Log In
Log In
Log In
Log In
Oncology
49.89M
Log In
Log In
Log In
Log In
Oncology Growth
47.33%
Log In
Log In
Log In
Log In
Transplantation
36.87M
Log In
Log In
Log In
Log In
Transplantation Growth
45.20%
Log In
Log In
Log In
Log In
Genetic Test Kits
-
Log In
Log In
Log In
Log In
Genetic Test Kits Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Italy
87.50M
Log In
Log In
Log In
Log In
Europe, Middle East and Africa
62.10M
Log In
Log In
Log In
Log In
Europe, Middle East and Africa Growth
-55.45%
Log In
Log In
Log In
Log In
Germany
31.30M
Log In
Log In
Log In
Log In
North and South America
17.90M
Log In
Log In
Log In
Log In
North and South America Growth
29.71%
Log In
Log In
Log In
Log In
Sweden
11.10M
Log In
Log In
Log In
Log In
Sweden Growth
11.00%
Log In
Log In
Log In
Log In
Asia
7.00M
Log In
Log In
Log In
Log In
Asia Growth
14.75%
Log In
Log In
Log In
Log In